Oruka Therapeutics Inc. Common Stock vs Seaboard Corporation Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Seaboard Corporation Common Stock trades at $4,019 (market cap $3.80B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Seaboard Corporation Common Stock pays a 0.23% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Seaboard Corporation Common Stock for 0 Days on average.
| ORKA | SEB | |
|---|---|---|
Market Cap | $5.18B | $3.80B |
Volume | 490,798 | 9,086 |
Sector | Health | Industrials |
52-Week High | $113.08 | $5.96K |
52-Week Low | $26.19 | $3.22K |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $4.57B |
Dividend Yield | — | 0.23% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Seaboard Corporation is a diversified agribusiness and transportation company operating through pork production, commodity trading and milling, marine cargo shipping, liquid fuels, power generation, and turkey production segments, including its Seaboard Foods and Butterball businesses. It operates across North America, the Caribbean, South America, Africa, and Europe.
Read more on SEB →